Strategic Partnerships Inpeco is actively pursuing collaboration with major diagnostic players such as QIAGEN and Diasorin to develop integrated automation solutions for QuantiFERON IGRA workflow, signaling a pathway to co-developed systems and extended market reach in infectious disease testing.

End-to-End Automation The company positions itself as a global leader in Total Laboratory Automation with ongoing development of track-based and end-to-end workflows, indicating opportunities to upsell comprehensive automation packages to labs seeking full process integration and traceability.

Expansion in TB Testing New fully automated QuantiFERON latent TB testing workflow and aliquoting and intelligent incubation innovations suggest a focus area for labs handling TB screening and latent infection studies, offering a gateway to expand across CLIA/CAP labs and regional distributors.

Clinical Lab Footprint With deployments exceeding 2800 systems in 78 countries and a global development and manufacturing presence, there is strong evidence of scalable sales motion, partner-ready solutions, and potential for expansion in Europe, the US, and Asia-Pacific regions.

Targeted Commercial Tie-ins Recent strategic agreement with Grifols for transfusion medicine automation underscores appetite for cross-vertical lab automation in blood banks and clinical laboratories, presenting opportunities to cross-sell track-based solutions to blood center networks and hospital labs.